DNMT1 and T-cell large granular lymphocyte leukemia: In a case report, decitabine, a DNA methyltransferase 1 (DNMT1) epigenetic modulator, demonstrated successful outcomes in a T-LGLL patient refractory to red blood cell transfusion (14).